Murphy is a well-respected investor newsletter writer. His claim to fame was making the right call on biotech behemoths Amgen, Biogen, and Genentech (recently bought out by Roche).
http://seekingalpha.com/instablog/128006-michael-murphy/1133-dendreon-a-360-stock-or-is-that-too-low
He's obviously bullish on DNDN, but a peak into his newsletter reveals he's also bullish on MELA and ARNA.
Do your due diligence and good luck.
Disclosure: I am long DNDN and ARNA.
Monday, April 20, 2009
Subscribe to:
Post Comments (Atom)
Posts
![[Most Recent Quotes from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_t_gN7rmLOcXWyrOt1rNox0aDzcRzILptwX4sVvyZIIlJfyJk4khjUvWsOEy4oLjUGtcciEUItzIndHPAXjszoRfHtsAJ13NpkXEGEQbJgLijWFZ_GC-jJUJ-Bzixyk6ykCbQ=s0-d)
![[Most Recent Quotes from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tMmzuqIGa3zixo-lYIW48kcw289O3ZSCrthEhg_mwGEnsAUEW_K1uwE9LBZw08JI7RSpvBHPetR2K1WltgtVxTAE3iCiMiBxeTFBnKDgLvcz2TAL2ZNCDnPhX2VupVtUUds2lW=s0-d)
![[Most Recent USD from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_thhPfGe_PG-Lk6nhIzKo2oLseF7Wi4BEoQVghJSdzFftM-Ra52xmvz9-ZGnK8OiJY4buhibUSOFsuz5Fv7pOxrxEfg7GJQkdM66s2Em7RRrCZxdGpDOs9M=s0-d)
No comments:
Post a Comment